Search results for "">d"

showing 4 items of 4 documents

Chemical Compositions and Antioxidant Activities of Essential Oils, and Their Combinations, Obtained from Flavedo By-Product of Seven Cultivars of Si…

2022

In this work, seven Citrus aurantium essential oils (EOs) derived from flavedo of cultivars ‘Canaliculata’, ‘Consolei’, ‘Crispifolia’, ‘Fasciata’, ‘Foetifera’, ‘Listata’, and ‘Bizzaria’ were investigated. EOs were also combined in 1:1 (v/v) ratio to identify possible synergism or antagonism of actions. GC-MS analysis was done to investigate Eos’ phytochemical profiles. The antioxidant activity was studied by using a multi-target approach based on FRAP, DPPH, ABTS, and β-carotene bleaching tests. A great difference was observed in EOs’ phytochemical profiles. d-limonene (33.35–89.17%) w…

<i>Citrus aurantium</i>; GC-MS analysis; essential oil combinations; <span style="font-variant: small-caps">d</span>-limonene; PCA analysis; global antioxidant scoreOrganic ChemistryPharmaceutical ScienceGC-MS analysid-limoneneAnalytical Chemistryglobal antioxidant scoreChemistry (miscellaneous)Drug Discoveryessential oil combinationMolecular MedicinePCA analysiPhysical and Theoretical ChemistryCitrus aurantiumMolecules
researchProduct

Fructose-1,6-Bisphosphate Protects Hippocampal Rat Slices from NMDA Excitotoxicity

2019

Effects of fructose 1,6-bisphosphate (F-1,6-P2) towards N-methyl-d-aspartate NMDA excitotoxicity were evaluated in rat organotypic hippocampal brain slice cultures (OHSC) challenged for 3 h with 30 &mu

Fructose 16-bisphosphateExcitotoxicityFructose-bisphosphate aldolaseorganotypic hippocampal brainslice culturesmedicine.disease_causeHippocampuslcsh:Chemistrychemistry.chemical_compoundenergymetabolismFructose-Bisphosphate Aldolaseenergy metabolismfructose-16-bisphosphatelcsh:QH301-705.5Spectroscopy<i>N</i>-methyl-<span style="font-variant: small-caps">d</span>-aspartatebiologyChemistryorganotypic hippocampal brain slice culturesGlyceraldehyde-3-Phosphate DehydrogenasesGeneral MedicineComputer Science ApplicationsFructose-BisphosphataseNeuroprotective AgentsNMDA receptorexcitotoxicityPhosphofructokinaseN-methyl-d-aspartatemedicine.medical_specialtyN-MethylaspartateFructose 16-bisphosphataseCatalysisArticleInorganic ChemistryNecrosisInternal medicinemitochondrial dysfunctionmedicineAnimalsPhysical and Theoretical ChemistryRats WistarMolecular BiologySettore BIO/10 - BIOCHIMICAOrganic ChemistryAldolase AMetabolismPurine NucleosidesRatsEndocrinologylcsh:Biology (General)lcsh:QD1-999Phosphofructokinases6-bisphosphatebiology.proteinfructose-1; 6-bisphosphate; N-methyl-d-aspartate; excitotoxicity; energymetabolism; mitochondrial dysfunction; organotypic hippocampal brainslice culturesfructose-1
researchProduct

Polyaspartamide-based nanoparticles loaded with fluticasone propionate and the in vitro evaluation towards cigarette smoke effects

2017

This paper describes the evaluation of polymeric nanoparticles (NPs) as a potential carrier for lung administration of fluticasone propionate (FP). The chosen polymeric material to produce NPs was a copolymer based on α,β-poly(N-2-hydroxyethyl)-d,l-aspartamide (PHEA) whose backbone was derivatised with different molecules, such as poly(lactic acid) (PLA) and polyethylenglycol (PEG). The chosen method to produce NPs from PHEA-PLA-PEG2000 was the method based on high-pressure homogenization and subsequent solvent evaporation by adding Pluronic F68 during the process and trehalose before lyophilisation. Obtained colloidal FP-loaded NPs showed a slightly negative surface charge and nanometric d…

Materials scienceFluticasone propionate (FP)General Chemical EngineeringNanoparticle02 engineering and technologyPolymeric nanoparticle010402 general chemistry01 natural sciencesαβ-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA)Articlealpha beta-poly-(N-2-hydroxyethyl)-D L-aspartamide (PHEA)">dPoly(lactic acid) (PLA)lcsh:ChemistryColloidchemistry.chemical_compoundPEG ratioCopolymer?Organic chemistryGeneral Materials ScienceSurface charge?-poly-(N-2-hydroxyethyl)-dαβ-poly-(N-2-hydroxyethyl)-technology industry and agriculture">l-aspartamide (PHEA)Poly(ethylene glycol) (PEG)respiratory system021001 nanoscience & nanotechnologyTrehaloseIn vitro0104 chemical sciencesLactic acidαβ-poly-(<i>N</i>-2-hydroxyethyl)-<span style="font-variant: small-caps;">d</span><span style="font-variant: small-caps;">l</span>-aspartamide (PHEA); poly(lactic acid) (PLA); poly(ethylene glycol) (PEG); polymeric nanoparticles; fluticasone propionate (FP)polymeric nanoparticleschemistrylcsh:QD1-999l-aspartamide (PHEA); poly(lactic acid) (PLA); poly(ethylene glycol) (PEG); polymeric nanoparticles; fluticasone propionate (FP)0210 nano-technologyNuclear chemistry
researchProduct

Margination of Fluorescent Polylactic Acid-Polyaspartamide based Nanoparticles in Microcapillaries In Vitro: the Effect of Hematocrit and Pressure.

2017

The last decade has seen the emergence of vascular-targeted drug delivery systems as a promising approach for the treatment of many diseases, such as cardiovascular diseases and cancer. In this field, one of the major challenges is carrier margination propensity (i.e., particle migration from blood flow to vessel walls); indeed, binding of these particles to targeted cells and tissues is only possible if there is direct carrier–wall interaction. Here, a microfluidic system mimicking the hydrodynamic conditions of human microcirculation in vitro is used to investigate the effect of red blood cells (RBCs) on a carrier margination in relation to RBC concentration (hematocrit) and pressure drop…

Pharmaceutical ScienceNanoparticle02 engineering and technologyPolymeric nanoparticleHematocrit01 natural sciencesAnalytical Chemistrychemistry.chemical_compoundDrug Delivery SystemsPolylactic acidDrug Discoveryαβ-poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA)medicine.diagnostic_testMolecular StructureChemistry">l-aspartamide (PHEA)poly(ethylene glycol) (PEG)Microfluidic Analytical Techniques021001 nanoscience & nanotechnologypolymeric nanoparticlesBiochemistryHematocritmarginationChemistry (miscellaneous)Drug deliveryMolecular Medicine0210 nano-technologyDrug carrier">PolyestersIn Vitro Techniquesα β-poly-(N-2-hydroxyethyl)-D010402 general chemistryFluorescenceArticleMicrocirculationαβ-poly-(N-2-hydroxyethyl)-<span style="font-variant: small-caps;">d</span><span style="font-variant: small-caps;"></span><span style="font-variant: small-caps;">l</span>-aspartamide (PHEA); poly(lactic acid) (PLA); poly(ethylene glycol) (PEG); polymeric nanoparticles; marginationlcsh:QD241-441Rhodaminelcsh:Organic chemistrypoly(lactic acid) (PLA)PEG ratiomedicineHumansPhysical and Theoretical ChemistryParticle Sizeα β-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA)αβ-poly-(N-2-hydroxyethyl)-RhodaminesMicrocirculationOrganic Chemistry0104 chemical sciencesBiophysicsNanoparticles">dPeptidesMolecules (Basel, Switzerland)
researchProduct